In-silico and In-vivo Investigations Reveal Ameliorative Potential of Myricetin Against Doxorubicin-induced Myocardial Damage via Modulation of NF-κB Signaling Pathway
Authors
Sameer N. Goyal (ORCID: https://orcid.org/0000-0002-5241-7049)
Purvaj G. Barote
Sanjay N. Awathale (ORCID: https://orcid.org/0000-0002-8793-3318)
Harshal D. Pawar (ORCID: https://orcid.org/0009-0004-0813-8554)
Kartik T. Nakhate (ORCID: https://orcid.org/0000-0002-7585-441X)
Chemotherapy-induced cardiotoxicity and mitigation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
In-silico and In-vivo Investigations Reveal Ameliorative Potential of Myricetin Against Doxorubicin-induced Myocardial Damage via Modulation of NF-κB Signaling Pathway
Sameer N. Goyal, Purvaj G. Barote, Sanjay N. Awathale, Harshal D. Pawar et al.
Journal
Current Protein and Peptide Science
Topics
Chemotherapy-induced cardiotoxicity and mitigation
article
In-silico and In-vivo Investigations Reveal Ameliorative Potential of Myricetin Against Doxorubicin-induced Myocardial Damage via Modulation of NF-κB Signaling Pathway
Sameer N. Goyal, Purvaj G. Barote, Sanjay N. Awathale, Harshal D. Pawar, Kartik T. Nakhate, Sumit Rathod, Abdulla Sherikar, M.I. Sayyed, Kapil Suchal, U. N. Harle
article en
Abstract
No abstract available for this paper.
Publication Tag
Current Protein and Peptide ScienceVol. 26
Institutions
University of Pittsburgh (US), Amneal (India) (IN), Shri Vile Parle Kelavani Mandal (IN)
OpenAlex Percentile
Openalex Percentile: Top 58%
Topics
Chemotherapy-induced cardiotoxicity and mitigation